Inhaled Mannitol (Bronchitol) for Cystic Fibrosis

Date: May 31, 2021 Issue #:  1625Summary:  The FDA has approved mannitol powder for oral inhalation (Bronchitol– Chiesi) as add-on maintenance treatment to improve pulmonary function in adults with cystic fibrosis (CF). This product has been available in Europe for the same indication since 2012. Another formulation of mannitol inhalation powder(Aridol) is approved in the US for assessment of bronchial hyperresponsiveness.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Source Type: research